IREN Ltd
For the period ended Mar 31, 2026. Filed May 8, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 8, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Unaudited Condensed Consolidated Statements of Stockholders’ Equity
IREN Limited
Condensed Consolidated Statements of Stockholders’ Equity
(Unaudited, in USD thousands, except share and per share data)
Nine Months Ended March 31, 2026
| Ordinary shares · Additional Paid-in Capital · AccumulatedDeficit · Accumulated Other ComprehensiveIncome (Loss) · TotalStockholders’Equity | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shares | Amount | ||||||||||
| Balance, June 30, 2025 | 257,211,899 | $2,355,056 | $88,672 | $(596,167) | $(30,073) | $1,817,488 | |||||
| Issuance of Ordinary shares – at-the-market offering, net of issuance costs | 23,041,102 | 599,918 | — | — | — | 599,918 | |||||
| Issuance of Ordinary shares – restricted stock units | 314,237 | 1,787 | — | — | — | 1,787 | |||||
| Issuance of Ordinary shares – stock options | 2,309,065 | 8,827 | — | — | — | 8,827 | |||||
| Stock-based compensation | — | 68,994 | — | — | 68,994 | ||||||
| Change in foreign currency translation adjustments | — | — | — | — | (5,458) | (5,458) | |||||
| Net income (loss) | — | — | — | 384,611 | — | 384,611 | |||||
| Balance, September 30, 2025 | 282,876,303 | 2,965,588 | 157,666 | (211,556) | (35,531) | 2,876,167 | |||||
| Issuance of Ordinary shares – at-the-market offering, net of issuance costs | — | — | — | — | — | — | |||||
| Issuance of Ordinary shares – Equity Offering, net of issuance costs | 39,699,102 | 1,634,847 | — | — | — | 1,634,847 | |||||
| Issuance of Ordinary shares – restricted stock units | 9,122,733 | 67,806 | — | — | — | 67,806 | |||||
| Issuance of Ordinary shares – stock options | 61,039 | 131 | — | — | — | 131 | |||||
| Stock-based compensation | — | — | (9,574) | — | — | (9,574) | |||||
| Repurchase of the 2030 Convertible Notes and 2029 Convertible Notes | — | — | (981,018) | — | — | (981,018) | |||||
| Reclassification of 2030 Prepaid Forward Contract and 2029 Prepaid Forward Contract | — | — | (665,400) | — | — | (665,400) | |||||
| Reclassification of 2030 Capped Call Transactions and 2029 Capped Call Transactions | — | — | (259,600) | — | — | (259,600) | |||||
| Change in foreign currency translation adjustments | — | — | — | — | 3,241 | 3,241 | |||||
| Net income (loss) | — | — | — | (155,407) | — | (155,407) | |||||
| Balance, December 31, 2025 | 331,759,177 | 4,668,372 | (1,757,926) | (366,963) | (32,290) | 2,511,193 | |||||
| Issuance of Ordinary shares – at-the-market offering, net of issuance costs | 8,857,303 | 376,806 | — | — | — | 376,806 | |||||
| Issuance of Ordinary shares – restricted stock units | 363,486 | 1,905 | — | — | — | 1,905 | |||||
| Issuance of Ordinary shares – stock options | — | — | — | — | — | — | |||||
| Stock-based compensation | — | — | 29,559 | — | — | 29,559 | |||||
| Change in foreign currency translation adjustments | — | — | — | — | (7,108) | (7,108) | |||||
| Net income (loss) | — | — | — | (247,827) | — | (247,827) | |||||
| Balance, March 31, 2026 | 340,979,966 | 5,047,083 | (1,728,367) | (614,790) | (39,398) | 2,664,528 | |||||
IREN Limited
Condensed Consolidated Statements of Stockholders’ Equity (continued)
(Unaudited, in USD thousands, except share and per share data)
Nine Months Ended March 31, 2025
| Ordinary shares · Additional Paid-in Capital · AccumulatedDeficit · Accumulated Other ComprehensiveIncome (Loss) · TotalStockholders’Equity | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shares | Amount | ||||||||||
| Balance, June 30, 2024 | 186,367,686 | $1,764,289 | $51,286 | $(683,109) | $(34,994) | $1,097,471 | |||||
| Issuance of Ordinary shares – at-the-market offering, net of issuance costs | 9,138,867 | 73,145 | — | — | — | 73,145 | |||||
| Issuance of Ordinary shares – restricted stock units | 1,132,733 | 4,758 | — | — | — | 4,758 | |||||
| Issuance of Ordinary shares – stock options | 490,196 | 991 | — | — | — | 991 | |||||
| Stock-based compensation | — | 3,160 | — | — | 3,160 | ||||||
| Change in foreign currency translation adjustments | — | — | — | — | 1,854 | 1,854 | |||||
| Net income (loss) | — | — | — | (51,703) | — | (51,703) | |||||
| Balance, September 30, 2024 | 197,129,482 | 1,843,183 | 54,446 | (734,812) | (33,140) | 1,129,677 | |||||
| Issuance of Ordinary shares – at-the-market offering, net of issuance costs | 16,268,604 | 141,818 | — | — | — | 141,818 | |||||
| Issuance of Ordinary shares – restricted stock units | 14,940 | 5 | — | — | — | 5 | |||||
| Issuance of Ordinary shares – stock options | 91,962 | 99 | — | — | — | 99 | |||||
| Stock-based compensation | — | — | 7,893 | — | — | 7,893 | |||||
| Change in foreign currency translation adjustments | — | — | — | — | (11,959) | (11,959) | |||||
| Net income (loss) | — | — | — | (21,888) | — | (21,888) | |||||
| Balance, December 31, 2024 | 213,504,988 | $1,985,105 | $62,339 | $(756,700) | $(45,099) | $1,245,645 | |||||
| Issuance of Ordinary shares – at-the-market offering, net of issuance costs | 10,022,708 | 107,263 | — | — | — | 107,263 | |||||
| Issuance of Ordinary shares – restricted stock units | 29,881 | 140 | — | — | — | 140 | |||||
| Issuance of Ordinary shares – stock options | — | — | — | — | — | — | |||||
| Stock-based compensation | — | — | 7,630 | — | — | 7,630 | |||||
| Change in foreign currency translation adjustments | — | — | — | — | 24 | 24 | |||||
| Net income (loss) | — | — | — | (16,144) | — | (16,144) | |||||
| Balance, March 31, 2025 | 223,557,577 | $2,092,508 | $69,969 | $(772,844) | $(45,075) | $1,344,558 | |||||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.